A next generation CAR-T platform that provides physiological T cell signaling.
A next generation NK-CAR platform
Bispecific and multi-specific SIR-T and NK-CAR platforms
Universal SIR and NK-CAR platforms
Angeles platforms are fully compatible with allogeneic use
Use of Dasatinib to control CRS and other complications associated with cell therapies
A novel platform for providing selective NF-kappa B co-stimulus to CAR-T, TCR-T and other cell therapy products
A novel luciferase based assay to measure expression and affinity of cell therapy products
Copyright © 2021 Angeles Therapeutics, Inc - All Rights Reserved.